Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net loss	$ (8,965)	$ (6,678)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization expense	18,190	16,811
Stock/equity-based compensation expense	9,468	641
Contingent consideration expense	1,303	257
Deferred income taxes	(1,247)	(2,775)
Loss on disposal of property and equipment	48
Non-cash interest expense, including loss on extinguishment of debt	4,125	4,017
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(4,127)	(617)
Accounts receivable, net	(2,166)	(2,190)
Unbilled receivables	(468)	(1,813)
Other assets	(864)	(346)
Accounts payable	(1,072)	1,385
Accrued expenses and other current liabilities	8,856	7,309
Deferred revenue	2,047	526
Other long-term liabilities	(707)	3,118
Net cash provided by operating activities	24,421	19,645
Cash flows from investing activities:
Acquisition of businesses, net of cash acquired		(25,518)
Purchases of property and equipment, including costs capitalized for development of internal-use software	(4,521)	(5,392)
Net cash used in investing activities	(4,521)	(30,910)
Cash flows from financing activities:
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions	331,989
Proceeds from issuance of common stock to General Atlantic (IC), L.P. in connection with the Corporate Conversion (Note 11)	43,236
Payment to settle fractional shares related to Class A-2 shareholders in connection with the Corporate Conversion (Note 11)	(43,236)
Proceeds from issuance of long-term debt		31,250
Repayment of long-term debt	(114,174)
Payment of debt issuance costs	(1,146)
Payment of debt extinguishment costs	(90)
Payments of related party notes	(5,900)
Payments of contingent consideration	(1,868)	(1,500)
Proceeds from exercise of stock/equity-based options	1,577	4,981
Repurchase and retirement of common shares	(51)
Payment of initial public offering costs	(5,293)
Net cash provided by financing activities	205,044	34,731
Net increase in cash, cash equivalents and restricted cash	224,944	23,466
Cash, cash equivalents and restricted cash at beginning of period	29,650	6,184
Cash, cash equivalents and restricted cash at end of period	254,594	29,650
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	254,294	29,350
Restricted cash within other assets	$ 300	$ 300
Restricted Cash and Cash Equivalents, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Assets Noncurrent	Other Assets Noncurrent
Total cash, cash equivalents, and restricted cash	$ 254,594	$ 29,650
Supplemental cash flow information:
Cash paid for interest	5,350	5,662
Cash paid for taxes	206	78
Supplemental disclosure of non-cash investing and financing activities:
Additions to property and equipment included in accounts payable and accrued expenses	178	59
Deferred initial public offering costs included in accrued expenses	286
Debt issuance costs included in accrued expenses	$ 23
Fair value of contingent consideration recorded in purchase accounting		$ 4,608